[go: up one dir, main page]

AR031717A1 - Metodo para producir una proteina que es dominio de una proteina que es una proteina funcional; proceso para expresar selectivamente exones que codifican dicha proteina; gen recombinante integrado en el gen de celulas eucariotas, que comprende dicho exon; constructos de dna para producir dichas prot - Google Patents

Metodo para producir una proteina que es dominio de una proteina que es una proteina funcional; proceso para expresar selectivamente exones que codifican dicha proteina; gen recombinante integrado en el gen de celulas eucariotas, que comprende dicho exon; constructos de dna para producir dichas prot

Info

Publication number
AR031717A1
AR031717A1 ARP010103647A ARP010103647A AR031717A1 AR 031717 A1 AR031717 A1 AR 031717A1 AR P010103647 A ARP010103647 A AR P010103647A AR P010103647 A ARP010103647 A AR P010103647A AR 031717 A1 AR031717 A1 AR 031717A1
Authority
AR
Argentina
Prior art keywords
protein
gen
domain
producing
eucariot
Prior art date
Application number
ARP010103647A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of AR031717A1 publication Critical patent/AR031717A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe y reivindica un método para producir dominios proteicos funcionales que son fragmentos de productos primarios de la traduccion, que comprenden al menos un dominio proteico codificado por subgrupos de secuencias exonicas específicas. El método está basado en la integracion recombinante homologa de una unidad reguladora en el gen eucariotico que codifica el producto de la traduccion primaria; a nivel de la region genomica intronica, inmediatamente adyacente a las secuencias exonicas que codifican dichos dominios proteicos funcionales. Específicamente se trata de obtener una proteína que es el dominio de una proteína funcional, indistintamente C-terminal o N-terminal, proveniente de la traduccion primaria de un gen. Se describen y reivindican además los objetos restantes mencionados en el título.
ARP010103647A 2000-08-01 2001-07-31 Metodo para producir una proteina que es dominio de una proteina que es una proteina funcional; proceso para expresar selectivamente exones que codifican dicha proteina; gen recombinante integrado en el gen de celulas eucariotas, que comprende dicho exon; constructos de dna para producir dichas prot AR031717A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0018876.3A GB0018876D0 (en) 2000-08-01 2000-08-01 Method of producing polypeptides

Publications (1)

Publication Number Publication Date
AR031717A1 true AR031717A1 (es) 2003-10-01

Family

ID=9896767

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103647A AR031717A1 (es) 2000-08-01 2001-07-31 Metodo para producir una proteina que es dominio de una proteina que es una proteina funcional; proceso para expresar selectivamente exones que codifican dicha proteina; gen recombinante integrado en el gen de celulas eucariotas, que comprende dicho exon; constructos de dna para producir dichas prot

Country Status (20)

Country Link
US (1) US8048645B2 (es)
EP (1) EP1305411B1 (es)
JP (1) JP5068916B2 (es)
CN (1) CN1468304B (es)
AR (1) AR031717A1 (es)
AT (1) ATE398174T1 (es)
AU (1) AU7573901A (es)
BR (1) BR0112979A (es)
CA (1) CA2415768C (es)
CY (1) CY1110431T1 (es)
DE (1) DE60134410D1 (es)
DK (1) DK1305411T3 (es)
ES (1) ES2305091T3 (es)
GB (1) GB0018876D0 (es)
IL (1) IL154212A0 (es)
NO (1) NO330897B1 (es)
PT (1) PT1305411E (es)
SI (1) SI1305411T1 (es)
WO (1) WO2002010372A1 (es)
ZA (1) ZA200300827B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056986A2 (en) * 2002-12-20 2004-07-08 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US7601518B2 (en) * 2003-06-10 2009-10-13 Nsgene A/S Secretion of neublastin
US8053191B2 (en) 2006-08-31 2011-11-08 Westend Asset Clearinghouse Company, Llc Iterative nucleic acid assembly using activation of vector-encoded traits
WO2011053957A2 (en) * 2009-11-02 2011-05-05 Gen9, Inc. Compositions and methods for the regulation of multiple genes of interest in a cell
US10457935B2 (en) 2010-11-12 2019-10-29 Gen9, Inc. Protein arrays and methods of using and making the same
JP6118725B2 (ja) 2010-11-12 2017-04-19 ジェン９・インコーポレイテッドＧｅｎ９，ＩＮＣ． 核酸合成のための方法およびデバイス
LT2944693T (lt) 2011-08-26 2019-08-26 Gen9, Inc. Kompozicijos ir būdai, skirti nukleorūgščių didelio tikslumo sąrankai
US9150853B2 (en) 2012-03-21 2015-10-06 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
EP4001427A1 (en) 2012-04-24 2022-05-25 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
EP2864531B2 (en) 2012-06-25 2022-08-03 Gen9, Inc. Methods for nucleic acid assembly and high throughput sequencing
KR102122632B1 (ko) 2013-08-05 2020-06-16 트위스트 바이오사이언스 코포레이션 드 노보 합성된 유전자 라이브러리
CA3253836A1 (en) 2015-02-04 2025-12-01 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly
US10669304B2 (en) 2015-02-04 2020-06-02 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
US9981239B2 (en) 2015-04-21 2018-05-29 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
KR20180050411A (ko) 2015-09-18 2018-05-14 트위스트 바이오사이언스 코포레이션 올리고핵산 변이체 라이브러리 및 그의 합성
KR102794025B1 (ko) 2015-09-22 2025-04-09 트위스트 바이오사이언스 코포레이션 핵산 합성을 위한 가요성 기판
CN115920796A (zh) 2015-12-01 2023-04-07 特韦斯特生物科学公司 功能化表面及其制备
EP3500672A4 (en) 2016-08-22 2020-05-20 Twist Bioscience Corporation NOVO SYNTHESIZED NUCLEIC ACID BANKS
KR102217487B1 (ko) 2016-09-21 2021-02-23 트위스트 바이오사이언스 코포레이션 핵산 기반 데이터 저장
KR102514213B1 (ko) 2016-12-16 2023-03-27 트위스트 바이오사이언스 코포레이션 면역 시냅스의 변이체 라이브러리 및 그의 합성
EP4556433A3 (en) 2017-02-22 2025-08-06 Twist Bioscience Corporation Nucleic acid based data storage
AU2018234629A1 (en) 2017-03-15 2019-10-17 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
SG11201912057RA (en) 2017-06-12 2020-01-30 Twist Bioscience Corp Methods for seamless nucleic acid assembly
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
GB2581620A (en) 2017-09-11 2020-08-26 Twist Bioscience Corp GPCR binding proteins and synthesis thereof
KR102889470B1 (ko) 2017-10-20 2025-11-21 트위스트 바이오사이언스 코포레이션 폴리뉴클레오타이드 합성을 위한 가열된 나노웰
CN112041438B (zh) 2018-01-04 2025-05-23 特韦斯特生物科学公司 基于dna的数字信息存储
CN112639130B (zh) 2018-05-18 2024-08-09 特韦斯特生物科学公司 用于核酸杂交的多核苷酸、试剂和方法
CN119708086A (zh) 2018-12-26 2025-03-28 特韦斯特生物科学公司 高度准确的从头多核苷酸合成
KR20210144698A (ko) 2019-02-26 2021-11-30 트위스트 바이오사이언스 코포레이션 항체 최적화를 위한 변이 핵산 라이브러리
SG11202109322TA (en) 2019-02-26 2021-09-29 Twist Bioscience Corp Variant nucleic acid libraries for glp1 receptor
CA3144644A1 (en) 2019-06-21 2020-12-24 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
US12173282B2 (en) 2019-09-23 2024-12-24 Twist Bioscience, Inc. Antibodies that bind CD3 epsilon
US12091777B2 (en) 2019-09-23 2024-09-17 Twist Bioscience Corporation Variant nucleic acid libraries for CRTH2
AU2021350195A1 (en) 2020-09-28 2023-05-04 Vestaron Corporation Mu-diguetoxin-dc1a variant polypeptides for pest control
US20240374761A1 (en) 2021-05-05 2024-11-14 Radius Pharmaceuticals, Inc. Animal model having homologous recombination of mouse pth1 receptor
WO2023122805A1 (en) 2021-12-20 2023-06-29 Vestaron Corporation Sorbitol driven selection pressure method
WO2024026406A2 (en) 2022-07-29 2024-02-01 Vestaron Corporation Next Generation ACTX Peptides

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646438B1 (fr) * 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
SG122763A1 (en) * 1989-11-06 2006-06-29 Cell Genesys Inc Production of proteins using homologous recombination
EP0505500B1 (en) * 1989-12-22 1997-07-30 Applied Research Systems Ars Holding N.V. Endogenous gene expression modification with regulatory element by way of homologous recombination
US5272071A (en) * 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
WO1993004169A1 (en) * 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5733761A (en) * 1991-11-05 1998-03-31 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US6063630A (en) * 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
CN1256986C (zh) * 1993-12-02 2006-05-24 转移染色体治疗公司 蛋白质的生产和蛋白质的输送
US5545817A (en) * 1994-03-11 1996-08-13 Calgene, Inc. Enhanced expression in a plant plastid
US6229006B1 (en) 1995-12-22 2001-05-08 Smithkline Beecham Corporation Use of antisense oligodeoxynucleotides to produce truncated proteins
CN100582230C (zh) 1997-09-26 2010-01-20 阿瑟西斯公司 通过载体构建体与细胞dna的非同源重组来表达内源基因
US7063960B2 (en) * 1997-12-12 2006-06-20 The Rockefeller University Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
US6436707B1 (en) * 1998-03-27 2002-08-20 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
AU751520B2 (en) * 1998-03-27 2002-08-15 Lexicon Pharmaceuticals, Inc. Vectors for gene mutagenesis and gene discovery
JP3688118B2 (ja) * 1998-05-22 2005-08-24 独立行政法人科学技術振興機構 遺伝子トラップ用ベクターと、このベクターを用いた遺伝子トラップ方法

Also Published As

Publication number Publication date
ATE398174T1 (de) 2008-07-15
US8048645B2 (en) 2011-11-01
NO20030443D0 (no) 2003-01-28
JP2004504840A (ja) 2004-02-19
US20040053362A1 (en) 2004-03-18
CN1468304A (zh) 2004-01-14
NO330897B1 (no) 2011-08-08
EP1305411A1 (en) 2003-05-02
AU7573901A (en) 2002-02-13
CY1110431T1 (el) 2015-04-29
CA2415768A1 (en) 2002-02-07
ES2305091T3 (es) 2008-11-01
DK1305411T3 (da) 2008-09-01
WO2002010372A1 (en) 2002-02-07
EP1305411B1 (en) 2008-06-11
HK1059281A1 (en) 2004-06-25
BR0112979A (pt) 2003-07-08
JP5068916B2 (ja) 2012-11-07
SI1305411T1 (sl) 2008-10-31
IL154212A0 (en) 2003-07-31
GB0018876D0 (en) 2000-09-20
NO20030443L (no) 2003-03-25
CN1468304B (zh) 2011-01-19
WO2002010372A8 (en) 2002-02-28
ZA200300827B (en) 2004-02-25
PT1305411E (pt) 2008-07-03
CA2415768C (en) 2011-05-17
DE60134410D1 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
AR031717A1 (es) Metodo para producir una proteina que es dominio de una proteina que es una proteina funcional; proceso para expresar selectivamente exones que codifican dicha proteina; gen recombinante integrado en el gen de celulas eucariotas, que comprende dicho exon; constructos de dna para producir dichas prot
Wu et al. Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family
Tucker The thrombospondin type 1 repeat superfamily
Cohen-Salmon et al. Otogelin: a glycoprotein specific to the acellular membranes of the inner ear
Wang et al. Interorganellar regulation of lysosome positioning by the Golgi apparatus through Rab34 interaction with Rab-interacting lysosomal protein
Huber et al. Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex
ATE302267T1 (de) Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert
Nardi et al. Expression of lacunin, a large multidomain extracellular matrix protein, accompanies morphogenesis of epithelial monolayers in Manduca sexta
DE69834267D1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
AR039003A1 (es) Composiciones y metodos para alterar el contenido de tocotrienoles
EP1392846A4 (en) METHOD AND COMPOSITIONS FOR MODIFYING THE PROCESSING OF APOLIPOPROTEIN B mRNA
GB9924957D0 (en) Novel treatment
GEP20166454B (en) Sclerostin binding agents
ATE437652T1 (de) Verwendung von hmgb1 zur aktivierung dendritischer zellen
BR0215406A (pt) Fitase termotolerante para ração animal
ATE496892T1 (de) Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
Shin et al. Matrix metalloproteinase-20 over-expression is detrimental to enamel development: a Mus musculus model
BRPI0411843A (pt) promotores rps21 e beta-actina e usos destes
PE20021098A1 (es) ANTICUERPOS ESPECIFICOS DE CD44v6
Uinuk‐Ool et al. Phylogeny of antigen‐processing enzymes: cathepsins of a cephalochordate, an agnathan and a bony fish
ATE387220T1 (de) Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis
Müller et al. Towards an understanding of the molecular basis of immune responses in sponges: the marine demosponge Geodia cydonium as a model
AR035881A1 (es) Un metodo para determinar la predisposicion de un individuo a una condicion de piel, un sistema para determinar dicha predisposicion, uso de un polipeptido que comprende la secuencia de un alelo de profilagrina, o una de sus variantes o fragmentos o un polinucleotido que codifica cualquiera de estos
DE50212186D1 (de) Expressionskassetten zur transgenen expression von nukleinsäuren
ATE398177T1 (de) Verfahren zur behandlung von erkrankungen im zusammenhang mit apoe

Legal Events

Date Code Title Description
FG Grant, registration